The company and many of its peers saw dramatic lifts on the back of new Presidential remarks.Investors caught quite the serious buzz from marijuana stocks on Tuesday, thanks largely to President Trump's strongest indication so far that he will get the ball rolling on the drug's rescheduling. One title that wafted well higher in price was Curaleaf Holdings (CURLF +23.18%), which was up by almost 25% when the smoke cleared. Will the Trump card be played?This came in an answer to a reporter's question whether ...

President Trump just gave cannabis investors something they've been waiting for.Shares of Tilray Brands (TLRY +28.04%) soared today, finishing up 27.5%. The jump came as the S&P 500 lost 0.3% and the Nasdaq Composite gained 0.2%.The cannabis company's stock is rising after President Donald Trump confirmed that his administration is looking into reclassifying marijuana -- a move that could be a game changer for the cannabis industry.NASDAQ : TLRYTilray BrandsToday's Change( 28.04 %) $ 3.06Current Price$ 13.9 ...

For hardly the first time in recent days, investors have become excited about the prospect of a significant change in U.S. drug laws.Will he or won't he? This is the question that's been front of mind for many marijuana stock investors over the past few days, as both credible media reports and President Trump himself fueled speculation that he will begin the process of decriminalizing the drug. Comments from the President late Monday injected new bullishness into weed stocks the following day. Sector mainst ...

President Donald Trump on Monday reiterated that he is weighing whether to reclassify marijuana as a less dangerous drug, a statement that mirrors similar comments he made earlier this year and during his 2024 presidential campaign. Speaking to reporters in the Oval Office, the president said he was considering an executive order to reclassify marijuana as a Schedule III drug."We are considering that. A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research th ...

The legal status of marijuana in the U.S. remains scattered and confusing.A sharp pull-back in marijuana stocks dinged the value of Tilray Brands (TLRY 10.04%) shares on Monday. At the end of last week, investor hopes rose that President Donald Trump would take an important step toward the de facto legalization of the drug, but those hopes didn't materialize on Monday. Investors eagerly sold out of Tilray, leaving the stock with a 10% loss that trading session. Awaiting a signaturePot stock bulls came out i ...

President Donald Trump told reporters on Monday he is weighing an executive order to reclassify marijuana as a Schedule III substance. The potential action could transform the cannabis market, reduce legal punishments and allow for easier scientific research.TLRY stock is moving. See the chart and price action here. “We are looking at that very strongly,” Trump said in response to reports that he is looking at directing agencies to treat marijuana as a Schedule III drug.Read Next: Elon Musk Prepares SpaceX ...

Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on U.S. President Joe Biden "to take action on cannabis clemency before the November general election” October 24, 2022 in Washington, DC.Pot stocks failed to light up for a second day on Monday even after President Donald Trump confirmed he's considering an executive order loosening regulations on marijuana.The Amplify Seymour Cannabis ETF (CNBS) took a leg up in afternoon trading after Trump said he was weighing reclassi ...

Key Takeaways Weed stocks dropped Monday afternoon, reversing early gains on hopes President Trump could soon issue an executive order reclassifying marijuana. An expected reclassification from a Schedule I to a Schedule III drug would help companies in the sector reduce their taxes and relax banking restrictions. Weed stocks aren't flying so high anymore. Shares of Tilray Brands (TLRY) dropped nearly 5%, Canopy Growth (CGC) slipped 3%, and other cannabis stocks also lost ground in recent trading, reve ...

Key Takeaways TLRY rose 44.1% on Friday after reports that an executive order could reclassify marijuana under federal law.Tilray Brands rallied as the reclassification could ease banking limits, tax burdens and investment barriers.Before the surge, TLRY was down 36.6% YTD, highlighting how quickly sentiment shifts on reform signals.Shares of cannabis producer Tilray Brands, Inc. (TLRY) surged 44.1% on Friday, Dec. 12, 2025, on reports that President Donald Trump is expected to sign an executive order as ea ...

The cannabis business might soon be a lot more lucrative.Shares of Tilray Brands (TLRY +43.89%) surged 65% this past week, according to data provided by S&P Global Market Intelligence. Investors are hopeful that the Trump administration will move to lessen costly regulations on the beleaguered cannabis industry. A highly anticipated executive orderPresident Donald Trump is reportedly contemplating a reclassification of marijuana from a Schedule I drug to a Schedule III drug, according to The Washington Post ...